INSULIN DEGLUDEC AND LIRAGLUTIDE

1658 reported adverse events

Drug classes: GLP-1 Receptor Agonist [EPC] Insulin Analog [EPC]

These side effects are most commonly reported by patients taking INSULIN DEGLUDEC AND LIRAGLUTIDE:

# Side effect Count
0 BLOOD GLUCOSE INCREASED 192
1 NAUSEA 122
2 ACUTE KIDNEY INJURY 88
3 DIARRHOEA 87
4 VOMITING 87
5 HYPOGLYCAEMIA 73
6 GLYCOSYLATED HAEMOGLOBIN INCREASED 62
7 LACTIC ACIDOSIS 58
8 DECREASED APPETITE 53
9 ASTHENIA 50
See all common reactions for INSULIN DEGLUDEC AND LIRAGLUTIDE

INSULIN DEGLUDEC AND LIRAGLUTIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LUNG HERNIA 6 0.1053
1 COMA ACIDOTIC 3 0.0357
2 INFECTIVE MYOSITIS 4 0.0240
3 JOINT ABSCESS 6 0.0172
4 DEVICE LOOSENING 10 0.0116
5 DIABETIC METABOLIC DECOMPENSATION 15 0.0108
6 RED BLOOD CELL ABNORMALITY 5 0.0052
7 STREPTOCOCCAL SEPSIS 6 0.0051
8 PREMATURE EJACULATION 3 0.0047
9 HYPERPHOSPHATAEMIA 10 0.0046
See all enriched reactions for INSULIN DEGLUDEC AND LIRAGLUTIDE